Skip to content
value.today

Pascal Medical Corp

Total raised
$6 M
2 rounds on record
Latest round
$3 M
Jun 2026
First round on record
Dec 2024
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pascal Medical Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2026$3 MNo. 2$2 to $10 million

Pascal Medical Corp: Raise no. 2, Jun 2026

Investors in this round

39 investors had bought by the notice of Jul 27, 2026: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barbara Dale Boyan · Executive Officer, Director
  • James Craig Sevey · Executive Officer
  • Richard William Hall · Executive Officer, Director
  • Thomas William Gardner · Executive Officer, Director
  • William Gregory Smart · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total offering amount includes $92,436.05 worth of converting securities and warrants to purchase shares of common stock at an aggregate exercise price of up to $6,298.82.”

Signed by Thomas William Gardner, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 27, 2026. Read the notice at the SEC.

equitySEC
Dec 2024$3 MNo. 1$2 to $10 million

Pascal Medical Corp: Raise no. 1, Dec 2024

Investors in this round

32 investors had bought by the notice of Jun 5, 2025: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barbara Dale Boyan · Executive Officer, Director, Promoter
  • Richard Dale Hall · Executive Officer, Director, Promoter
  • Donald Dale Quartel Jr. · Director
  • William Gregory Smart · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total offering amount inlcudes $508,338 worth of convertible securities.”

Signed by Barbara Dale Boyan, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jun 5, 2025. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pascal Medical Corp chose not to state its revenue in its newest notice of a funding round (Jul 2026).

    SEC Form D · Jul 2026

  • The industry group it chose in its notices: Other.

    SEC Form D · Jul 2026

That is all the official record says: Pascal Medical Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pascal Medical Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 39 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pascal Medical Corp
NameRoleNamed in
Barbara Dale BoyanExecutive officerJul 2026
James Craig SeveyExecutive officerJul 2026
Richard William HallExecutive officerJul 2026
Thomas William GardnerExecutive officerJul 2026
William Gregory SmartExecutive officerJul 2026
Richard Dale HallExecutive officerJun 2025
Barbara Dale BoyanDirectorJul 2026
Richard William HallDirectorJul 2026
Thomas William GardnerDirectorJul 2026
William Gregory SmartDirectorJul 2026
Donald Dale Quartel Jr.DirectorJun 2025
Richard Dale HallDirectorJun 2025
Barbara Dale BoyanPromoterJun 2025
Richard Dale HallPromoterJun 2025